Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era

Since the development of the Radiation Therapy Oncology Group-Recursive Partitioning Analysis (RTOG-RPA) risk classes for high-grade glioma, radiation therapy in combination with temozolomide (TMZ) has become standard care. While this combination has improved survival, the prognosis remains poor in...

Descripción completa

Detalles Bibliográficos
Autores principales: Paravati, Anthony J., Heron, Dwight E., Landsittel, Douglas, Flickinger, John C., Mintz, Arlan, Chen, Yi-Fan, Huq, M. Saiful
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Clinical Study – Patient Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151374/
https://www.ncbi.nlm.nih.gov/pubmed/21181233
http://dx.doi.org/10.1007/s11060-010-0499-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151374/
https://www.ncbi.nlm.nih.gov/pubmed/21181233
http://dx.doi.org/10.1007/s11060-010-0499-8

Ejemplares similares